235 related articles for article (PubMed ID: 17576832)
1. Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci.
Schlievert PM
Antimicrob Agents Chemother; 2007 Sep; 51(9):3056-62. PubMed ID: 17576832
[TBL] [Abstract][Full Text] [Related]
2. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.
Stevens DL
Emerg Infect Dis; 1995; 1(3):69-78. PubMed ID: 8903167
[TBL] [Abstract][Full Text] [Related]
3. Combination of flucloxacillin and gentamicin inhibits toxic shock syndrome toxin 1 production by Staphylococcus aureus in both logarithmic and stationary phases of growth.
van Langevelde P; van Dissel JT; Meurs CJ; Renz J; Groeneveld PH
Antimicrob Agents Chemother; 1997 Aug; 41(8):1682-5. PubMed ID: 9257741
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
Bohach GA; Fast DJ; Nelson RD; Schlievert PM
Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
[TBL] [Abstract][Full Text] [Related]
5. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.
Stevens DL; Tanner MH; Winship J; Swarts R; Ries KM; Schlievert PM; Kaplan E
N Engl J Med; 1989 Jul; 321(1):1-7. PubMed ID: 2659990
[TBL] [Abstract][Full Text] [Related]
6. Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production.
Schlievert PM; Blomster DA; Kelly JA
Obstet Gynecol; 1984 Nov; 64(5):666-71. PubMed ID: 6436761
[TBL] [Abstract][Full Text] [Related]
7. Erythrogenic toxins A, B and C: occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome.
Reichardt W; Müller-Alouf H; Alouf JE; Köhler W
FEMS Microbiol Lett; 1992 Dec; 100(1-3):313-22. PubMed ID: 1478466
[TBL] [Abstract][Full Text] [Related]
8. Menaquinone analogs inhibit growth of bacterial pathogens.
Schlievert PM; Merriman JA; Salgado-Pabón W; Mueller EA; Spaulding AR; Vu BG; Chuang-Smith ON; Kohler PL; Kirby JR
Antimicrob Agents Chemother; 2013 Nov; 57(11):5432-7. PubMed ID: 23959313
[TBL] [Abstract][Full Text] [Related]
9. Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin.
Schlievert PM; Gocke JE; Deringer JR
Clin Infect Dis; 1993 Jul; 17(1):26-31. PubMed ID: 8353243
[TBL] [Abstract][Full Text] [Related]
10. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources.
Bonventre PF; Weckbach L; Staneck J; Schlievert PM; Thompson M
Infect Immun; 1983 Jun; 40(3):1023-9. PubMed ID: 6189784
[TBL] [Abstract][Full Text] [Related]
11. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C.
Smith RJ; Schlievert PM; Himelright IM; Baddour LM
Diagn Microbiol Infect Dis; 1994 Aug; 19(4):245-7. PubMed ID: 7851088
[TBL] [Abstract][Full Text] [Related]
12. Streptococcal toxic shock syndrome: a description of 14 cases from North Yorkshire, UK.
Barnham MR; Weightman NC; Anderson AW; Tanna A
Clin Microbiol Infect; 2002 Mar; 8(3):174-81. PubMed ID: 12010172
[TBL] [Abstract][Full Text] [Related]
13. Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness.
Lee PK; Schlievert PM
J Clin Microbiol; 1989 Aug; 27(8):1890-2. PubMed ID: 2504778
[TBL] [Abstract][Full Text] [Related]
14. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus.
Stevens DL; Ma Y; Salmi DB; McIndoo E; Wallace RJ; Bryant AE
J Infect Dis; 2007 Jan; 195(2):202-11. PubMed ID: 17191165
[TBL] [Abstract][Full Text] [Related]
15. Toxic shock syndrome: major advances in pathogenesis, but not treatment.
Low DE
Crit Care Clin; 2013 Jul; 29(3):651-75. PubMed ID: 23830657
[TBL] [Abstract][Full Text] [Related]
16. A VLU complicated by severe group a streptococcal infection resulting in necrotising fasciitis and septic shock: a case report.
Meagher H; Corkery M; Concannon L; Kavanagh E
J Wound Care; 2014 Oct; 23(10 Suppl):S14-7. PubMed ID: 25289649
[TBL] [Abstract][Full Text] [Related]
17. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci.
Mascini EM; Jansze M; Schouls LM; Verhoef J; Van Dijk H
Int J Antimicrob Agents; 2001 Oct; 18(4):395-8. PubMed ID: 11691576
[TBL] [Abstract][Full Text] [Related]
18. Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins.
Schlievert PM
J Am Coll Surg; 1996 Jul; 183(1):19-24. PubMed ID: 8673303
[TBL] [Abstract][Full Text] [Related]
19. Toxic Shock Syndrome: A Literature Review.
Atchade E; De Tymowski C; Grall N; Tanaka S; Montravers P
Antibiotics (Basel); 2024 Jan; 13(1):. PubMed ID: 38247655
[TBL] [Abstract][Full Text] [Related]
20. Streptococcal toxic shock-like syndrome.
Wolf JE; Rabinowitz LG
Arch Dermatol; 1995 Jan; 131(1):73-7. PubMed ID: 7826100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
